Interaction between sodium and angiotensin II: Role of dose and duration of treatment

Current Opinion in Nephrology and Hypertension

Volumn 8, Issue 2, 1999, Pages 193-198

  Simon, Geza ^a,b   Illyes, Gyorgy ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESSENTIAL HYPERTENSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SODIUM METABOLISM; SYMPATHETIC INNERVATION;

EID: 0032968434     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199903000-00007     Document Type: Review

References (40)

1. Schmieder RE, Beil AH. Salt intake and cardiac hypertrophy. In: Hypertension: pathophysiology, diagnosis and management, 2nd edn Laragh JH, Brenner BM (editors). New York: Raven Press; 1995. pp. 1327-1333
2. Avolio AP, Clyde CM, Beard TC, Cooke HM, Ho KL, O'Rourke MF. Improved arterial distensibility in normotensive subjects on a low salt diet. Arteriosclerosis 1986; 6:166-169.
3. Leenen FHH, Yuan B Dietary-sodium-induced cardiac remodeling in spontaneously hypertensive versus Wistar-Kyoto rat. J Hypertens 1998; 16:885-892. This is a review of the investigations conducted by the authors of the effects of short- and long-term dietary sodium supplementation on cardiac mass and design of rats.
4. Franz IW, Tonnesmann U, Muller JFM. Timecourse of complete normalization of left ventricular hypertrophy during long-term antihypertensive therapy with angiotensin-converting enzyme inhibitors. Am J Hypertens 1998; 11:631-639. The authors found a continuous decrease in left ventricular mass index for up to 38 months in hypertensive patients with left-ventricular hypertrophy receiving quinapril therapy.
5. Simon G, Illyes G, Csiky B. Structural vascular changes in hypertension: role of angiotensin II, dietary sodium supplementation, blood pressure and time. Hypertension 1998; 32:654-660. The development of structural vascular changes in angiotensin II-treated rats is not only dose-dependent but also time-dependent, that is, a lesser dose of angiotensin II applied long enough may produce the same changes as a larger dose administered for a shorter period of time.
6. Simon G, Csiky B. Effect of neonatal sympathectomy on the development of structural vascular changes in angiotensin II-treated rats. J Hypertens 1998; 16:77-84.
7. Mohring J Pathogenesis of malignant hypertension: experimental evidence from the renal hypertensive rat. Clin Nephrol 1975; 5:167-174.
8. Schiffrin EL. Endothelin: potential role in hypertension and vascular hypertrophy. Hypertension 1995; 25:1135-1143.
9. Sterzel RB, Luft FC, Gao Y, Shnerman J, Briggs JB, Ganten D, et al Renal disease and the development of hypertension in salt-sensitive Dahl rats. Kidney Int 1988; 33:1119-1129.
10. Folkow B. Critical review of studies on salt and hypertension. Clin Exp Hypertens 1992; A14:1-14.
11. Ferrario CM. Neurogenic actions of angiotensin II. Hypertension 1983; 5 (Suppl. V):V-73-V-79.
12. Zimmerman BG, Sybertz EJ, Wong PC. Interaction between sympathetic and renin-angiotensin system J Hypertens 1984; 2:581-587.
13. Purdy RE, Weber MA. Angiotensin II amplification of α-adrenergic vasoconstriction: role of receptor reserve. Circ Res 1988; 63:748-757.
14. Rankin LI, Luft FC, Henry DP, Gibbs RS, Weinberger MH Sodium intake alters the effects of norepinephrine on blood pressure. Hypertension 1981; 3:650-656
15. De Champlain J, Krakoff LR, Axelrod J. Relationship between sodium intake and norepinephrine storage during the development of experimental hypertension. Cire Res 1968; 23:479-491.
16. Simon G. Increased vascular wall sodium in hypertension: where is it, how does it get there and what does it do there? Clin Sci 1990; 78:533-540.
17. Csiky B, Simon G. Effect of neonatal sympathectomy on development of angiotensin II-induced hypertension. Am J Physiol 1997; 272:H648-656 The development of angiotensin II-induced hypertension and structural vascular changes was investigated in young adult Sprague-Dawley rats that were sympathectomized in the neonatal period.
18. Csiky B, Simon G. Synergistic vascular effects of dietary sodium supplementation and angiotensin II administration. Am J Physiol 1997; 273:H1275-1282. The authors found that short-term administration of a high sodium diet to Sprague-Dawley rats potentiated vasoconstrictor responses to angiotensin II by facilitating sympathetic neurotransmission, and the long-term administration of a high sodium diet raised systolic blood pressure by potentiating the trophic vascular effects of angiotensin II.
19. Gunther S, Gimbrone MA, Alexander RW. Regulation by angiotensin II of its receptors in resistance blood vessels. Nature 1980; 287:230-232.
20. Wang DH, Du Y. Regulation of vascular type 1 angiotensin II receptor in hypertension and sodium loading: role of angiotensin II. J Hypertens 1998; 16:467-475 Dietary sodium supplementation (4% salt) of Wistar rats upregulates arterial angiotensin II type 1 receptors, which can be prevented by the simultaneous administration of a subpressor dose of angiotensin II.
21. Nickening G, Strehlow K, Roeling J, Zolk O, Knorr A, Bohm M. Salt induces vascular AT1 receptor overexpression in vitro and in vivo. Hypertension 1998; 31:1272-1277.
22. Wang DH, Du Y, Yao A, Hu Z. Regulation of type 1 angiotensin II receptor and its subtype gene expression in kidney by sodium loading and angiotensin II infusion. J Hypertens 1996; 14:1409-1415.
23. Schmid C, Castrop H, Reitbauer J, Della Bruna R, Kurtz A Dietary salt intake modulates angiotensin II type 1 receptor gene expression. Hypertension 1997; 29:923-929.
24. Haynes WG, Webb DJ. Endothelin as a regulator of cardiovascular function in health and disease. J Hypertens 1998, 16:1081-1098. This article is an excellent review of the molecular biology and physiology of endothelins and of the clinical relevance of their dysregulation.
25. Teunissen KE, Postma CT, Jaarsveld BC, Derkx FHM, Thien T. Endothelin and active renin levels in essential hypertension and hypertension with renal artery stenosis before and after percutaneous transluminal renal angioplasty. J Hypertens 1997; 15:1791-1796. Circulating endothelin levels did not differ among patients with essential hypertension and patients with hemodynamically significant (high renin) renal artery stenosis.
26. Barton M, Shaw S, d'Uscio L, Moreau P, Luscher TF. Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: role of ETA receptor for endothelin regulation. Biochem Biophys Res Commun 1997; 238:861-865.
27. Kassab S, Miller MT, Novak J, Reckelhoff J, Clower B, Granger JP. Endothelin- A receptor antagonism attenuates the hypertension and renal injury in Dahl saltsensitive rats. Hypertension 1998; 31:397-402. Endothelm-A receptor antagonism provides only partial protection against the development of hypertension and renal damage in salt-fed (8% salt) Dahl saltsensitive rats.
28. d'Uscio LV, Moreau P, Shaw S, Takase H, Barton M, Luscher TF. Effects of chronic ETA-receptor blockade in angiotensin II-induced hypertension. Hypertension 1997; 29:435-441.
29. Simon G, Abraham G. Angiotensin II administration as an experimental model of hypertension. In: Hypertension: pathophysiology, diagnosis and management, 2nd edn. Laragh JH, Brenner BM (editors). New York: Raven Press, 1995. pp. 1423-1435.
30. Smith JB, Brock TA. Analysis of angiotensin-stimulated sodium transport in cultured smooth muscle cells from rat aorta J Cell Physiol 1983; 114:284-290.
31. Simon G. Stimulation of vascular Na-K pump with subpressor angiotensin II in rats. Proc Soc Exp Biol Med 1992; 159:424-431.
32. Peiro C, Angulo J, Llergo JL, Rodriguez-Manas L, Marin J, Sanchez-Ferrer CF. Angiotensin II mediates cell hypertrophy in vascular smooth muscle cultures from hypertensive Ren-2 transgenic rats by amiloride- and furosemide-sensitive mechanism. Biochem Biophys Res Commun 1997; 240:367-371.
33. + currents in rat arterial smooth muscle cells through protein kinase C. J Physiol (Lond) 1997; 503:489-496.
34. Brown WJ, Brown FK, Krishan I. Exchangeable sodium and blood volume in normotensive and hypertensive humans on high and low sodium intake. Circulation 1971; 43:508-519
35. Komiya I, Yamada T, Takasu N, Asawa T, Akamine H, Yagi N, et al. An abnormal sodium metabolism in Japanese patients with essential hypertension, judged by sodium distribution, renal function and the renin-aldosterone system J Hypertens 1997; 15:65-72.
36. Carey DJ. Control of growth and differentiation of vascular cells by extracellular matrix proteins. Annu Rev Physiol 1991; 53:161-177.
37. Illyes G, Talarico PJ, Simon G. Different structural vascular changes in angiotensin II-treated, salt-fed and cold-stressed rats. J Hypertens 1998, 16 (Suppl. 2):S107.
38. Gu J-W, Anand V, Shek E, Moore MC, Brady AL, Kelly WC, Adair TH. Sodium induces hypertrophy of cultured myocardial myoblasts and vascular smooth muscle cells. Hypertension 1998; 31:1083-1087.
39. Simon G. Synergistic effect of angiotensin II and a high sodium diet on the vascular glycosaminoglycan synthesis of rats. Am J Hypertens 1998; 10:1216-1222. Angiotensin 11 stimulates proteoglycan synthesis of the arteries and veins of Sprague-Dawley rats; the response is potentiated by pretreatment of the rats with a high sodium diet (4% salt).
40. Hirawa N, Uehara Y, Gomi T, Ikeda T, Goto A, Omata M. High salt intake enhances susceptibility to renal injury induced by non-pressor dose of angiotensin II. Hypertension 1997; 30:497.